Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Cell Marque main competitors are Sanofi Genzyme, Cell Signaling Technology, and Medimmune.
Competitor Summary. See how Cell Marque compares to its main competitors:
| Company | Founding date | Zippia score | Headquarters | # of Locations | Revenue | Employees |
|---|---|---|---|---|---|---|
| 1994 | 3.9 | Rocklin, CA | 1 | $17.5M | 45 | |
| 1980 | 4.2 | Ann Arbor, MI | 1 | $47.0M | 401 | |
| 1999 | 4.3 | Danvers, MA | 3 | $48.0M | 500 | |
| 1982 | 4.8 | Norcross, GA | 1 | $380.0M | 1,125 | |
| 1981 | 4.8 | Cambridge, MA | 1 | $4.6B | 12,000 | |
| 1853 | 4.7 | Rochester, NY | 7 | $4.8B | 12,000 | |
| 1983 | 3.2 | Vienna, VA | 1 | $558,664 | 44 | |
McNeil Consumer Healthcare | 1879 | 4.3 | Fort Washington, PA | 1 | $46.2M | 17 |
| 1943 | 4.4 | Scottsdale, AZ | 1 | $190.0M | 3,000 | |
| 2008 | 4.6 | Marietta, GA | 1 | $348.9M | 690 | |
| 1987 | 4.7 | Gaithersburg, MD | 1 | $422.2M | 6,030 | |
| 1981 | 4.6 | Milpitas, CA | 1 | $1.5B | 2,400 |
Rate how well Cell Marque differentiates itself from its competitors.
| Company | Highest salary | Hourly salary |
|---|---|---|
Cell Marque | $34,033 | $16.36 |
McNeil Consumer Healthcare | $44,093 | $21.20 |
Medimmune | $43,801 | $21.06 |
CEL-SCI | $41,692 | $20.04 |
Cell Signaling Technology | $40,800 | $19.62 |
Bausch + Lomb | $38,216 | $18.37 |
Cayman Chemical | $37,716 | $18.13 |
MiMedx | $37,406 | $17.98 |
Sanofi Genzyme | $36,710 | $17.65 |
LifeScan | $33,388 | $16.05 |
Immucor | $33,085 | $15.91 |
Blood Heroes | $31,915 | $15.34 |
Do you work at Cell Marque?
Is Cell Marque able to compete effectively with similar companies?
| Job title | Male | Female |
|---|---|---|
| MiMedx | 45% | 55% |
| Immucor | 49% | 51% |
| Sanofi Genzyme | 51% | 49% |
| Bausch + Lomb | 56% | 44% |
| LifeScan | 57% | 43% |
| Cell Marque | - | - |
| Company | White | Hispanic or Latino | Black or African American | Asian | Unknown | Diversity score |
|---|---|---|---|---|---|---|
| 49% | 16% | 21% | 11% | 2% | 9.4 | |
| 59% | 16% | 13% | 9% | 4% | 9.9 | |
| 61% | 14% | 7% | 14% | 4% | 9.8 | |
| 53% | 14% | 21% | 10% | 3% | 9.8 | |
| 45% | 33% | 6% | 12% | 4% | 8.7 | |
| 48% | 12% | 17% | 18% | 5% | 9.9 |